(68)Ga-PSMA-11 PET/CT in restaging castration-resistant nonmetastatic prostate cancer: detection rate, impact on patients’ disease management and adequacy of impact

We aimed to evaluate the impact of prostate-specific membrane antigen ligand labelled with gallium-68 (PSMA-11) PET/CT in restaging patients with castration-resistant nonmetastatic prostate cancer (PCa). Thirty patients were included. At least one malignant focus was found in 27/30 patients (90%). T...

Descripción completa

Detalles Bibliográficos
Autores principales: Fourquet, Aloÿse, Aveline, Cyrielle, Cussenot, Olivier, Créhange, Gilles, Montravers, Françoise, Talbot, Jean-Noël, Gauthé, Mathieu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005887/
https://www.ncbi.nlm.nih.gov/pubmed/32034191
http://dx.doi.org/10.1038/s41598-020-58975-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7005887/
https://www.ncbi.nlm.nih.gov/pubmed/32034191
http://dx.doi.org/10.1038/s41598-020-58975-8

Ejemplares similares